These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study. Liu M; Ma Z; Guo X; Zhu J; Su J Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075 [TBL] [Abstract][Full Text] [Related]
11. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors. Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742 [TBL] [Abstract][Full Text] [Related]
12. Identification of incidental hepatic malignancy as photopenic defect on 99mTc-sestamibi myocardial perfusion imaging. Hardebeck CJ; Herman C; Auseon A Clin Nucl Med; 2013 Oct; 38(10):821-2. PubMed ID: 23797217 [TBL] [Abstract][Full Text] [Related]
13. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma. Bacovsky J; Scudla V; Myslivecek M; Nekula J; Vytrasová M Neoplasma; 2005; 52(4):302-6. PubMed ID: 16059646 [TBL] [Abstract][Full Text] [Related]
14. Serendipitous diagnosis of multiple myeloma during sestamibi myocardial perfusion imaging. Lette J; Cerino M; Demaria S; Eybalin MC; Levasseur A Clin Nucl Med; 2002 Nov; 27(11):832-3. PubMed ID: 12394147 [No Abstract] [Full Text] [Related]
15. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. Mileshkin L; Blum R; Seymour JF; Patrikeos A; Hicks RJ; Prince HM Eur J Haematol; 2004 Jan; 72(1):32-7. PubMed ID: 14962260 [TBL] [Abstract][Full Text] [Related]
16. Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes. Fallahi B; Beiki D; Salehi Y; Emami-Ardekani A; Fard-Esfahani A; Aghahosseini F; Haghighatafshar M; Eftekhari M Nucl Med Commun; 2017 Jan; 38(1):15-20. PubMed ID: 27749776 [TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease. Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Blocklet D; Schoutens A; Kentos A; Feremans W Eur J Nucl Med; 2001 Sep; 28(9):1430-2. PubMed ID: 11585304 [No Abstract] [Full Text] [Related]
19. Utility of ⁹⁹mTc-human serum albumin diethylenetriamine pentaacetic acid SPECT for evaluating endoleak after endovascular abdominal aortic aneurysm repair. Nakai M; Sato H; Sato M; Ikoma A; Sonomura T; Nishimura Y; Okamura Y AJR Am J Roentgenol; 2015 Jan; 204(1):189-96. PubMed ID: 25539256 [TBL] [Abstract][Full Text] [Related]
20. Evaluation by SPECT-CT of an incidental finding of a thymoma and breast cancer in a myocardial perfusion SPECT with 99mTc-MIBI. García-Talavera P; Olmos R; Sainz-Esteban A; Ruiz MÁ; González ML; Gamazo C Rev Esp Med Nucl Imagen Mol; 2013; 32(4):260-2. PubMed ID: 23267742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]